Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Roberts, Carly
DOB: 10-DEC-1969 (Age: 56)
Gender: female
Address:
2 Price meadow
LE4 Mitchellborough (United Kingdom)
ID: 9384-259853-9 (ECI)
Report
Date: 10-NOV-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
St Matthews Health & Community Centre
Malabar Road 62-66
LE1 4 Leicester (United Kingdom)
Specimen
Collected: 10-NOV-2023

Hematology

Test 10-NOV-2023 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 4.3 4.0 - 11.0 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 5.0 4.2 - 5.4 10*6/uL
Hemoglobin [Mass/volume] in Blood 15.8 12 - 16 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 43.5 36 - 46 %
MCV [Entitic mean volume] in Red Blood Cells by Automated count 90.2 80 - 100 fL
MCH [Entitic mass] by Automated count 28.2 27 - 33 pg
MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count 33.8 32 - 36 g/dL
Erythrocyte [DistWidth] in Blood by Automated count 13.0 11.5 - 14.5 %
Platelets [#/volume] in Blood by Automated count 262.7 150 - 450 10*3/uL

Chemistry

Test 10-NOV-2023 Reference Range Unit
Oxygen saturation in Arterial blood 75.0 L 95 - 100 %
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 380.1 0 - 450 pg/mL
Glucose [Mass/volume] in Serum or Plasma 79.0 65 - 99 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 11.3 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 0.8 0.5 - 1.1 mg/dL
Calcium [Mass/volume] in Serum or Plasma 9.0 8.6 - 10.3 mg/dL
Sodium [Moles/volume] in Serum or Plasma 143.2 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 5.2 H 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Serum or Plasma 106.8 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 20.2 L 22 - 32 mmol/L
Protein [Mass/volume] in Serum or Plasma 6.4 L 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.4 3.5 - 5.2 g/dL
Bilirubin.total [Mass/volume] in Serum or Plasma 1.1 0.1 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 110.4 H 32 - 91 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 8.8 7 - 56 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 35.1 10 - 40 U/L
Magnesium [Mass/volume] in Serum or Plasma 1.7 1.7 - 2.2 mg/dL
Cholesterol [Mass/volume] in Serum or Plasma 145.7 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 147.4 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 86.8 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 29.5 L 40 - 60 mg/dL
Hemoglobin A1c/Hemoglobin.total in Blood 5.1 4.0 - 5.6 %
Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method 0.0 0.0 - 19.9 pg/mL
Ferritin [Mass/volume] in Serum or Plasma 98.3 13 - 150 ug/L
Iron [Mass/volume] in Serum or Plasma 66.7 50 - 170 ug/dL
Iron binding capacity [Mass/volume] in Serum or Plasma 393.1 250 - 450 ug/dL
Iron saturation [Mass Fraction] in Serum or Plasma 17.2 15 - 50 %

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows marked hypoxemia (low arterial oxygen saturation), mild metabolic acidosis (low CO₂), mild hyperkalemia, low total protein, elevated alkaline phosphatase, and low HDL cholesterol. Other parameters, including cardiac markers and renal function, are within normal limits. Findings suggest possible hepatic or biliary dysfunction and risk for cardiovascular disease. Clinical correlation and further evaluation are recommended.